Research Site — Wilmington, North Carolina

Research Site is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Research Site has participated in 85 clinical trials with 14 currently active.

Therapeutic areas: Secondary Hyperparathyroidism, Chronic Kidney Disease, COPD (Chronic Obstructive Pulmonary Disease).

Sponsors: Amgen, AstraZeneca, Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site?

Research Site has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site conducted?

Research Site has 85 clinical trials on record, with 14 currently active. Their work covers Secondary Hyperparathyroidism, Chronic Kidney Disease, COPD (Chronic Obstructive Pulmonary Disease).

Is Research Site accredited by Crixeo Health?

Yes — Research Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Research Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.